Journey from Oral Sub mucous Fibrosis (Osmf) to Functional Disease-Free Mouth Opening

Oral Submucous Fibrosis (OSMF) is a potentially malignant disease that causes oral mucosa damage. It is a well-known chronic insidious disease, precancerous condition, an autoimmune and collagen-related disorder with a multifactorial cause associated with betel quid chewing and characterized by gradual hyalinization of the lamina propria. In the large literature available for OSMF, multiple staging systems have already been proposed by various authors. Some of the most essential staging systems are widely utilized in clinical practice, resulting in earlier diagnosis and treatment. The treatment of oral submucous fibrosis has been a source of contention since Schwartz initially described the ailment in 1952. An attempt is made to critically assess and update knowledge of current breakthroughs that increase comprehension of the etiology of the premalignant disease and its medical and surgical care, hence increasing life expectancy. The goal of this research is to present a specific treatment technique that combines surgery and active physiotherapy to increase jaw opening and prevent relapse. The current study made a small effort to maintain adequate, functional disease-free mouth opening and detect any growing malignant change as soon as possible.